The Enterprise Value as of June 2026 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is 161.10M

According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 161.10M. This represents a change of -21.07% compared to the average of 204.12M of the last 4 quarters.

X4 Pharmaceuticals, Inc. (XFOR) Historical Enterprise Value (quarterly & annually)

How has XFOR Enterprise Value performed in the past?

The mean historical Enterprise Value of X4 Pharmaceuticals, Inc. over the last ten years is 40.12M. The current 161.10M Enterprise Value has changed 40.06% with respect to the historical average. Over the past ten years (40 quarters), XFOR's Enterprise Value was at its highest in in the March 2026 quarter at 305.40M. The Enterprise Value was at its lowest in in the December 2017 quarter at -50404118.40.

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

X4 Pharmaceuticals, Inc. (XFOR) Average Enterprise Value

How has XFOR Enterprise Value performed in the past?

The current Enterprise Value of X4 Pharmaceuticals, Inc. (XFOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value vs. Peers

How is XFOR’s Enterprise Value compared to its peers?

X4 Pharmaceuticals, Inc.’s Enterprise Value is greater than Aligos Therapeutics, Inc. (6.87M), less than Karyopharm Therapeutics Inc. (355.32M), greater than FibroGen, Inc. (11.12M), greater than Mersana Therapeutics, Inc. (91.27M), greater than Kezar Life Sciences, Inc. (-11018667.00), greater than Senti Biosciences, Inc. (35.45M), greater than INmune Bio, Inc. (13.12M), greater than Skye Bioscience, Inc. (19.58M), greater than OnKure Therapeutics, Inc. (-134267880.00), greater than Tempest Therapeutics, Inc. (11.64M),

Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.